EVEROLIMUS IN DE NOVO RENAL TRANSPLANT RECIPIENTS

Por E. I. Prokopenko
Publicado em 2010-06-01

Cytomegalovirus infection after kidney transplantation: real progress and prospects for pathogenesis research, prevention and treatment

Por E. I. Prokopenko
Publicado em 2019-10-01

MAIN PATHOGENETIC MECHANISMS IN URINARY TRACT INFECTIONS AND UROSEPSIS AFTER ALLOGENIC KIDNEY TRANSPLANTATION

Por M. Krstić, A. V. Vatazin, E. I. Prokopenko
Publicado em 2011-06-01

Pharmacoeconomic analysis of everolimus immunosuppressive therapy for <i>de novo</i> kidney transplant recipients in Russia

Por N. A. Avxentyev, E. V. Derkach, E. I. Prokopenko
Publicado em 2019-05-01

SUCCESSFUL TREATMENT FOR ATYPICAL HEMOLYTIC UREMIC SYNDROME IN A PUERPERA

Por O. N. Ulitkina, Zh. S. Filippovskaya, E. I. Prokopenko, A. M. Ovezov, V. V. Likhvantsev
Publicado em 2016-01-01

Kidney transplantation using complement inhibitor in a patient suffering from atypical hemolytic-uremic syndrome associated with factor H antibodies: successful prevention of recur...

Por E. I. Prokopenko, S. A. Pasov, A. V. Vatazin, A. Ya. Tsalman, T. E. Pankratenko, G. A. Generalova
Publicado em 2020-07-01

ACUTE BACTERIAL TUBULOINTERSTITIAL NEPHRITIS OF RENAL ALLOGRAFT COMPLICATED BY SEPTIC SHOCK

Por M. Krstic, A. V. Vatazin, E. I. Prokopenko, A. B. Zulkarnaev, E. S. Stolyarevich, R. O. Kantaria
Publicado em 2013-05-01

Clinical characteristics and outcomes of COVID-19 in kidney transplant recipients

Por R. O. Kantariya, Ya. G. Moysyuk, E. I. Prokopenko, A. R. Karapityan, A. A. Ammosov, A. V. Makevnina, A. A. Gaydarova
Publicado em 2021-12-01